Stocks and Investing Stocks and Investing
Tue, February 21, 2023

Annabel Samimy Maintained (APLS) at Strong Buy with Increased Target to $75 on, Feb 21st, 2023


Published on 2024-10-28 01:46:09 - WOPRAI, Annabel Samimy
  Print publication without navigation


Annabel Samimy of Stifel, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $65 to $75 on, Feb 21st, 2023.

Annabel has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 3 agree with Annabel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $58 on, Tuesday, January 3rd, 2023
  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Thursday, November 10th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $43 on, Tuesday, November 8th, 2022


This is the rating of the analyst that currently disagrees with Annabel


  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $79 on, Tuesday, November 15th, 2022
Contributing Sources